Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vistakon Pharmaceuticals
Age
21–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
willing to comply with investigator's and protocol's instructions
patients signature on the informed consent document
open-angle glaucoma or ocular hypertension
currently prescribed timolol hemihydrate (once a day (QD) or twice a day (BID))or timolol maleate in sorbate QD as monotherapy or as a part of 2-drug therapy in at least one eye
You may not be if
inability to understand the trial procedures
inability to give informed consent
inability to understand, read, or write English
best corrected visual acuity of 20/200 or worse in each eye
current moderate to severe infectious or inflammatory condition of the eye or eyelids including
current moderate to severe dry eye syndrome
current chronic use of ocular corticosteroids, ocular surgery or intraocular laser surgery to either eye in the prior 3 months
treated with 3 or more glaucoma medicines in both eye
Clareo Health | A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs
